Calendar

Financial releases

Date Title  
Toggle Summary AbbVie to Present at 33rd Annual J.P. Morgan Healthcare Conference
NORTH CHICAGO, Ill. , Dec. 30, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 33 rd Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 14, 2015 . Bill Chase , executive vice president and chief financial officer, will make a formal presentation on the company at 11 a.m.
Toggle Summary AbbVie to Present at Goldman Sachs Healthcare CEOs Unscripted Conference
NORTH CHICAGO, Ill. , Dec. 23, 2014 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Tuesday, Jan. 6, 2015 . Richard A. Gonzalez , chairman and chief executive officer, will take part in a question and answer session at 2:15 p.m.
Toggle Summary AbbVie to Present at Jefferies 2014 Global Healthcare Conference
NORTH CHICAGO, Ill. , Nov. 17, 2014 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Jefferies 2014 Global Healthcare Conference in London on Thursday, Nov. 20, 2014 . Bill Chase , executive vice president and chief financial officer, will make a formal presentation on the company at
Toggle Summary AbbVie to Present at Credit Suisse 2014 Healthcare Conference
NORTH CHICAGO, Ill. , Nov. 5, 2014 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Credit Suisse 2014 Healthcare Conference on Thursday, Nov. 13, 2014 . Bill Chase , executive vice president and chief financial officer, will make a formal presentation on the company at 10 a.m.
Toggle Summary AbbVie Reports Third-Quarter 2014 Financial Results
- Reports Third-Quarter Adjusted EPS of $0.89, Up 8.5 Percent and Well Above the Previous Guidance Range of $0.77 to $0.79; Reports GAAP EPS of $0.31 - Significantly Raises 2014 Adjusted EPS Guidance Range to $3.25 to $3.27 from $3.06 to $3.16 (GAAP EPS Guidance Range is $1.15 to $1.17); 2014
Toggle Summary AbbVie Announces New $5 Billion Stock Repurchase Program and Increases Dividend
- Will announce third-quarter 2014 financial results on Oct. 31, 2014 - NORTH CHICAGO, Ill. , Oct. 20, 2014 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today authorized a new $5 billion stock repurchase program and increased the company's quarterly cash dividend by nearly 17
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Sept. 19, 2014 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.42 per share.  The cash dividend is payable Nov. 17, 2014 to stockholders of record at the close of business on Oct. 15, 2014 .
Toggle Summary AbbVie to Present at Morgan Stanley Global Healthcare Conference
NORTH CHICAGO, Ill. , Sept. 5, 2014 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 10, 2014 . Bill Chase , executive vice president and chief financial officer, will make a formal presentation on the company at 9:20 a.m.
Toggle Summary Revised GAAP earnings guidance for AbbVie Inc for the Financial Year ending December 31, 2014 and Third Quarter ending September 30, 2014; Confirms Adjusted Earnings Guidance
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION NORTH CHICAGO, Ill. , Sept.
Toggle Summary AbbVie Reports Second-Quarter 2014 Financial Results
- Reports Second-Quarter Adjusted EPS of $0.82, Above Previous Guidance Range of $0.75 to $0.77 (Reports GAAP EPS of $0.68) - Delivers Second-Quarter Revenue of $4.926 Billion, an Increase of 5.0 Percent Over Second-Quarter 2013 (Up 4.8 Percent On an Operational Basis); Revenue Up 12.3 Percent